According to the Zhitong Finance App, Luye Pharmaceutical (02186.HK) issued an announcement. On December 12, 2025, according to the terms of the subscription agreement, the issuance of exchangeable preferred shares has been completed. The issuer Luye Geneora Holding Limited (a wholly-owned subsidiary of the Company) has allocated and issued 1.5 million exchangeable preferred shares to subscribers.

According to the Zhitong Finance App, Luye Pharmaceutical (02186.HK) issued an announcement. On December 12, 2025, according to the terms of the subscription agreement, the issuance of exchangeable preferred shares has been completed. The issuer Luye Geneora Holding Limited (a wholly-owned subsidiary of the Company) has allocated and issued 1.5 million exchangeable preferred shares to subscribers.